Welcome to our dedicated page for Dalrada Financl news (Ticker: DFCO), a resource for investors and traders seeking the latest updates and insights on Dalrada Financl stock.
Dalrada Financial Corporation (DFCO), now identified in company communications as Dalrada Technology Group, Inc., generates news across clean energy, semiconductor deposition technology, precision manufacturing, and health care. Its press releases highlight developments within core segments such as Dalrada Climate Technology, Deposition Technology (Deptec), and Genefic Specialty Pharmacy.
News related to clean energy and climate technology often covers contracts, distribution agreements, and facility developments involving Dalrada’s heat pump technology. Examples include agreements for heat pump installations in European light industrial facilities and a master distribution agreement in the United States that targets sales of commercial and residential heat pump units across multiple regions.
Updates from Deposition Technology (Deptec) focus on advanced thin-film deposition and semiconductor-related tools. Company announcements have detailed the availability of the proprietary Spectroptix plasma spectrometer for advance ordering, as well as the establishment of a manufacturing and R&D facility in Portland, Oregon, to support deposition technology production and sales in North America and beyond.
In the health care segment, news frequently centers on Genefic, Inc. and Genefic Specialty Pharmacy. Communications include interviews and updates that describe revenue growth, expansion of specialty pharmacy services, and the operation of licensed diagnostic laboratories and an infusion pharmacy.
Dalrada’s news flow also includes corporate and governance updates, such as changes to its board of directors, executive appointments, and the selection of independent registered public accounting firms. Together, these items provide insight into the company’s strategic direction, operational focus, and corporate evolution from Dalrada Financial Corporation (DFCO) to Dalrada Technology Group, Inc. (DHTI).
Dalrada Corporation (OTCQB: DFCO) has announced that its Q1 2022 gross revenues are on track to exceed the combined gross revenues of the last eight quarters, pending review. CEO Brian Bonar emphasized Dalrada's commitment to providing innovative solutions in healthcare, clean energy, and technology. The company aims to meet current healthcare industry needs with affordable and accessible products. Established in 1982, Dalrada focuses on engineering, life sciences, and technology, with subsidiaries dedicated to impactful innovations.
Dalrada Corporation (OTCQB: DFCO) has announced the opening of two new subsidiaries under Dalrada Health. Pala Diagnostics is a national laboratory for COVID-19 testing, providing rapid antigen and PCR testing, while Sòlas Rejuvenation + Wellness offers advanced wellness programs. CEO Brian Bonar emphasized the importance of accurate health testing amidst the ongoing health crisis, highlighting Pala’s CLIA-certified lab's rapid results and mobile services. Dalrada Health aims to improve global health accessibility and affordability.
Dalrada Corporation (OTCQB: DFCO) has announced a joint venture between its subsidiary Dalrada Health and Vivera Pharmaceutical, Inc., creating Pala Diagnostics, LLC. This initiative aims to enhance COVID-19 testing capabilities, providing rapid results and life science testing services. Pala Diagnostics will initially offer EUA-approved rapid antigen tests and lab-based PCR testing. The collaboration seeks to support businesses and educational institutions as they reopen safely. The venture taps into Vivera's extensive healthcare network and expertise in pharmaceuticals and diagnostics.
Dalrada Corporation (OTCQB: DFCO) has appointed The Honorable Bijan R. Kian, Jose Arrieta, and Kyle McCollum to its Board of Directors. CEO Brian Bonar expressed enthusiasm for these appointments, highlighting their extensive experience in global trade, technology, and finance, which will enhance the company's initiatives in engineering, health, and clean energy. The new board members aim to accelerate Dalrada’s growth and innovation across its diverse sectors. With a commitment to disruptive solutions, Dalrada continues to strive for accessibility and positive change globally.
Dalrada Corporation (DFCO) announces its subsidiary, Dalrada Precision, has entered the eco-friendly degreaser market with Ignite Industrial Technologies’ products. These biodegradable cleaners offer a safer and more effective solution for manufacturing efficiency. The global cleaner and degreaser market is expected to grow, with the aftermarket projected to reach USD 42.63 billion by 2026. Ignite products are designed to be environmentally friendly, non-toxic, and effective for various industrial applications. This innovation positions Dalrada to capitalize on the increasing demand for sustainable cleaning solutions.
Dalrada Corporation (DFCO) announces a strategic partnership between its IT engineering subsidiary, Prakat Solutions, and ValueQwest Pte. Ltd. to enhance the digital transformation of global supply chains. A report indicates a substantial growth in the digital transformation market, predicting logistics spending to reach $75.5 billion by 2026, growing at a CAGR of 8.8%. This collaboration aims to develop scalable solutions and a talent pool of specialists in supply chain technologies, benefiting clients across 17 countries, including major firms like Microsoft and Oracle.
Dalrada Corporation (OTCQB: DFCO) has announced the appointment of Dr. David Bacon to its Board of Directors. Dr. Bacon brings over 22 years of active Navy experience and has been instrumental in evaluating funding proposals during the SARS-CoV-2 pandemic. His extensive background includes key roles in various defense-related health programs and significant scientific contributions, including 35 peer-reviewed publications. CEO Brian Bonar stated that Dr. Bacon’s expertise will enhance Dalrada Health's product development. The Board now comprises leaders from various sectors, focusing on innovative health and sustainability solutions.
Dalrada Corporation (OTCQB: DFCO) announced that its Technology Company, Prakat Solutions Inc., will sponsor the annual Global Accessibility Awareness Day (GAAD) event focused on digital inclusivity. This virtual event, starting on May 20th and spanning four days, will feature industry leaders and experts discussing accessibility challenges for users with disabilities. Prakat's initiative aims to improve digital experiences for over 1 billion individuals worldwide.
The event highlights Prakat's commitment to accessibility engineering and compliance with standards like the ADA and W3C.
Dalrada Corporation (DFCO) reported third-quarter financial results for fiscal year 2021, showing a remarkable 352% increase in revenues to $1,588,329, compared to $351,324 in Q3 2020. This quarter marks the company's top performance since its strategic shift in 2018. However, gross profit decreased to 46% from 57% in the previous quarter, attributed to rising raw material costs and investments in new subsidiaries. The company continues to expand its operations globally while focusing on sustainable solutions in healthcare and technology.
Dalrada Corporation (OTCQB: DFCO) announces the appointment of Mr. Kyle McCollum as Chief Financial Officer. With nearly 20 years of expertise in finance and business management, McCollum's background includes roles in investment strategy and compliance. CEO Brian Bonar highlighted that McCollum's experience will be crucial for Dalrada's global expansion. McCollum holds degrees in accounting from the University of Montana and has overseen operations in various industries, ranging from real estate to nutraceuticals. The company aims for robust growth through innovative solutions.
FAQ
What is the current stock price of Dalrada Financl (DFCO)?
What is the market cap of Dalrada Financl (DFCO)?
